MamStartup: Bioceltix is a biotech startup that does business in the veterinary industry – the company focuses on developing stem-cell-based biopharmaceuticals.
These biopharmaceuticals are a safer as well as more effective alternative to synthetic drugs, which treat only symptoms, not underlying causes. The aforementioned „synthetics” still remain by far the most popular choice when it comes to treating inflammation.
This exciting company is also among the finalist of the forth edition of Chivas Ventures – a contest created specifically to recognise the most socially-involved startups. Łukasz Bzdzion, CEO of Bioceltix, talked about the details surrounding the projects. If you want to know about the various stages of development, biggest challenges and when the product will actually become available to the market – read the full interview below.
Puls Biznesu about our plans: Bioceltix announces that it will soon debut on NewConnect – the company has recently completed the pre-IPO round. So far, the company has obtained a total of approx. PLN 20 million in financing for the development of a still innovative method of treating pets ...
ArticleForbes about Polish start-ups in the coronavirus crisis: “The year 2020 was a big challenge for companies, individual sectors of the economy and probably all of us. In the coming weeks and months of 2021 it will be similar. The condition of start-ups is no exception here. it is easier and ...
ArticleAccording to the „Investors’ Zone”, an interesting year is being prepared on the stock exchange: “This year, an exceptionally large group of companies is choosing NewConnect. As many as 63 companies declared their willingness to enter the alternative market, and several more in the ...
ArticleGazeta Wrocławska wrote about us: “Bioceltix is working on innovative biological medicines used in the treatment of common autoimmune and inflammatory diseases in companion animals. The company from Wrocław has something to fight for. This is indicated by the numbers on the global drug ...
ArticleWe create at Bioceltix veterinary biological medicines, and in 2020 we announced plans for a stock exchange debut and we obtained a permit from the Main Pharmaceutical Inspector to manufacture veterinary biological drugs. Despite the pandemic, we continue our projects without downtime. You can ...
ArticleWe hope you had a chance to tune in to „Radio dla Ciebie” during the „Let’s start with Innovation” („Innowacje na start”) show – that’s for ...
Read full
Another round of the prestigious contest designed for social-involved startups – Chivas Venture– is behind us. We are among the five ...
Read fullThe CEO of Bioceltix, Łukasz Bzdion, during an interview for Channel 4 of Polish Radio, answered question regarding the possibility of treating ...
Read full
